Company Profile
Coloplast provides the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and globally. Its operations are structured into Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions
Ostomy accessories under the Brava brand, as well as continence care products, such as Conveen Active urine bags. Its portfolio also includes SpeediCath catheters that offer catheterization for both genders, Peristeen Plus, a transanal irrigation system, and Peristeen Light, a low-volume transanal irrigation. Additionally, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand.
It also develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence.
Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories Tracheostomy care products under Tracoe brand. Founded in 1954, Coloplast is headquartered in Humlebæk, Denmark.